EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Pulmonary hypertension associated with lung diseases

Oksana A Shlobin iD, Yochai Adir iD, Joan A Barbera iD, Vincent Cottin iD, Sergio Harari iD, Etienne-Marie Jutant iD, Joanna Pepke-Zaba iD, Hossein-Ardeschir Ghofrani iD, Richard Channick iD

European Respiratory Journal · 2024-10 · 64 (4) · 2401200

DOI: 10.1183/13993003.01200-2024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Respiratory Journal, online erschienen am 29.08.2024. Verfasst von Oksana A Shlobin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Lung Disease and Transplant Program, Inova Schar Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, VA, USA. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 154-mal zitiert (Crossref) und nennt 238 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary hypertension (PH) associated with chronic lung disease (CLD) is both common and underrecognised. The presence of PH in the setting of lung disease has been consistently shown to be associated with worse outcomes. Recent epidemiological studies have advanced understanding of the heterogeneity of this patient population and shown that defining both the specific type of CLD as well as the severity of PH ( i.e. deeper phenotyping) is necessary to inform natural history and prognosis. A systematic diagnostic approach to screening and confirmation of suspected PH in CLD is recommended. Numerous uncontrolled studies and one phase 3 randomised, controlled trial have suggested a benefit in treating PH in some patients with CLD, specifically those with fibrotic interstitial lung disease (ILD). However, other studies in diseases such as COPD-PH showed adverse outcomes with some therapies. Given the expanding list of approved pharmacological treatments for pulmonary arterial hypertension, developing a treatment algorithm for specific phenotypes of CLD-PH is required. This article will summarise existing data in COPD, ILD and other chronic lung diseases, and provide recommendations for classification of CLD-PH and approach to the diagnosis and management of these challenging patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryLung Diseases, InterstitialPulmonary Disease, Chronic ObstructiveHumansLung DiseasesPrognosisChronic DiseaseRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Advanced Lung Disease and Transplant Program, Inova Schar Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, VA, USA.
  • Pulmonary Division, Lady Davis Carmel Medical Center, Faculty of Medicine Technion Institute of Technology, Haifa, Israel.
  • Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Barcelona, Spain.
  • Department of Respiratory Medicine, National Reference Centre for Rare Pulmonary Diseases, ERN-LUNG, Louis Pradel Hospital, Hospices Civils de Lyon and UMR 754, INRAE, Claude Bernard University Lyon 1, Lyon, France.
  • Unità Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria, MultiMedica IRCCS, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Respiratory Department, Centre Hospitalier Universitaire de Poitiers, INSERM CIC 1402, IS-ALIVE Research Group, University of Poitiers, Poitiers, France.

ORCID-Profile: Oksana A Shlobin, Yochai Adir, Joan A Barbera, Vincent Cottin, Sergio Harari, Etienne-Marie Jutant, Joanna Pepke-Zaba, Hossein-Ardeschir Ghofrani, Richard Channick

Zitieren

APA

Shlobin, O. A., Adir, Y., Barbera, J. A., Cottin, V., Harari, S., Jutant, E. M., Pepke-Zaba, J., Ghofrani, H. A., & Channick, R. (2024). Pulmonary hypertension associated with lung diseases. European Respiratory Journal, 64(4), 2401200. https://doi.org/10.1183/13993003.01200-2024

Vancouver

Shlobin OA, Adir Y, Barbera JA, Cottin V, Harari S, Jutant EM, et al. Pulmonary hypertension associated with lung diseases. European Respiratory Journal. 2024;64(4):2401200. doi:10.1183/13993003.01200-2024

BibTeX
@article{Shlobin2024,
  author = {Shlobin, Oksana A and Adir, Yochai and Barbera, Joan A and Cottin, Vincent and Harari, Sergio and Jutant, Etienne-Marie and Pepke-Zaba, Joanna and Ghofrani, Hossein-Ardeschir and Channick, Richard},
  title = {Pulmonary hypertension associated with lung diseases},
  journal = {European Respiratory Journal},
  year = {2024},
  volume = {64},
  number = {4},
  pages = {2401200},
  doi = {10.1183/13993003.01200-2024}
}
Kostenlos starten →